Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
67,430,361
-
Share change
-
-859,780
-
Total reported value
-
$5,169,445,951
-
Put/Call ratio
-
23%
-
Price per share
-
$76.62
-
Number of holders
-
378
-
Value change
-
-$66,319,216
-
Number of buys
-
191
-
Number of sells
-
136
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2021
As of 30 Sep 2021,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
378 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,430,361 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, RTW INVESTMENTS, LP, Champlain Investment Partners, LLC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, and AXA S.A..
This page lists
381
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.